Skip to main content

Alembic Pharmaceuticals - Touching Lives Over 100 Years

Corporate & Regd. Office : Alembic Road, Vadodara - 390 003, Gujarat,INDIA
Phone : +91 - 265 - 228 0550, +91 - 265 - 228 0880, +91 - 265 - 300 7000
Fax : +91 - 265 - 228 1508, +91 - 265 - 228 4728
Email :

Mumbai Office : 2nd floor , Prime Corporate Park, Behind ITC Grand Maratha Sheraton, Sahar Road, Andheri (E), Mumbai - 400 099, INDIA
Phone : +91 - 022 - 30611666

Manufacturing Facilities : Alembic Pharmaceuticals Limited, Samardung Basti,  Karek Block, South Sikkim -737132.

Alembic Research Centre : Division of Alembic Limited, Alembic Campus, Vadodara - 390003
For General Enquires: +91-265-300-7989, +91-265-300-7874
For Chemistry Requirements: +91-265-300-7652
For Bioequivalence / Bioavailability studies: +91-265-3007300

The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

The publicly listed entity that manufactures and markets generic pharmaceutical products across the globe has grown by leaps and bounds over the last century.

With an emphasis on innovation and technology, the company has established a state-of-the-art research facility – Alembic Research Centre (ARC)-including formulation research, and 150-bed bioequivalence facility at Vadodara, Gujarat. Additionally, APL has recently invested in ultra-modern R&D center at Hyderabad. APL is one of the leading players in the industry to have invested about 11% of its turnover in R&D.

As a growth strategy, the company has aggressively started investing in the international generics market with successful ANDA and DMF filings. APL has also filings across Canada, Europe, Australia, South Africa & Brazil. The company caters to the rest of the world markets through branded formulation sales.

The company aims to explore opportunities in the therapeutic areas such as Dermatology, Oncology, and Injectable Formulations. APL also has also co-promoted a company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.